Clopidogrel discontinuation and platelet reactivity following coronary stenting
about
Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugsGradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.Advances in the monitoring of anti-P2Y12 therapy.Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study.Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control.
P2860
Clopidogrel discontinuation and platelet reactivity following coronary stenting
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@en
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@nl
type
label
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@en
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@nl
prefLabel
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@en
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@nl
P2093
P2860
P50
P1476
Clopidogrel discontinuation and platelet reactivity following coronary stenting
@en
P2093
P2860
P356
10.1111/J.1538-7836.2010.04121.X
P407
P577
2011-01-01T00:00:00Z